Cargando…
Evaluation of pretreatment serum interleukin-6 and tumour necrosis factor alpha as a potential biomarker for recurrence in patients with oral squamous cell carcinoma
BACKGROUND: Oral squamous cell carcinoma (OSCC) constitutes 3 percent of all cancers with predominant occurrence in middle aged and elderly males. Tumour recurrence worsens disease prognosis and decreases quality of life in patients with OSCC. Proinflammatory cytokines such as interleukin-6 (IL-6) a...
Autores principales: | Skrinjar, Ivana, Brailo, Vlaho, Vidovic-Juras, Danica, Vucicevic-Boras, Vanja, Milenovic, Aleksandar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medicina Oral S.L.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523251/ https://www.ncbi.nlm.nih.gov/pubmed/25858079 http://dx.doi.org/10.4317/medoral.20373 |
Ejemplares similares
-
Salivary Cortisol Levels in Patients with Oral Lichen Planus—A Pilot Case-Control Study
por: Skrinjar, Ivana, et al.
Publicado: (2019) -
Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancer
por: Brailo, Vlaho, et al.
Publicado: (2012) -
Oral Adverse Reactions Caused by Over-the-Counter Oral Agents
por: Vucicevic Boras, Vanja, et al.
Publicado: (2015) -
Corrigendum to “Oral Adverse Reactions Caused by Over-the-Counter Oral Agents”
por: Boras, Vanja Vucicevic, et al.
Publicado: (2019) -
Topical NAVS naphthalan for the treatment of oral lichen planus and recurrent aphthous stomatitis: A double blind, randomized, parallel group study
por: Rogulj, Ana Andabak, et al.
Publicado: (2021)